Back
Reata Pharmaceuticals Stock Price Chart
Five Top Tech Stocks to Own Now
Click Here to Download the FREE Report
Buy
64
RETA
Reata Pharmaceuticals
Last Price:
93.69
Seasonality Move:
9.87%
7 Day Trial
ALL ACCESS PASS
$
7
The U.S. Government Just Invested $140 Million In WHAT?
And he shows you exactly how to take advantage right here, starting today.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RETA is experiencing slight selling pressure.
Reata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.71 | Buy |
| 20-day SMA: | 88.44 | Buy |
| 50-day SMA: | 93.83 | Sell |
| 200-day SMA: | 55 | Buy |
| 8-day EMA: | 92.69 | Buy |
| 20-day EMA: | 91.62 | Buy |
| 50-day EMA: | 89.11 | Buy |
| 200-day EMA: | 65.78 | Buy |
Reata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 54.82 | Buy |
| Chaikin Money Flow: | -37150 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.19 - 97.77) | Buy |
| Bollinger Bands (100): | (54.93 - 100.63) | Buy |
Reata Pharmaceuticals Technical Analysis
| May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | Jun-7 | Jun-8 | Jun-9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 26 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reata Pharmaceuticals Stock
Is Reata Pharmaceuticals Stock a Buy?
- Reata Pharmaceuticals share price is 93.80 while RETA 8-day simple moving average is 92.71, which is a Buy signal.
- The stock price of RETA is 93.80 while Reata Pharmaceuticals 20-day SMA is 88.44, which makes it a Buy.
- Reata Pharmaceuticals 50-day simple moving average is 93.83 while RETA share price is 93.80, making it a Sell technically.
- RETA stock price is 93.80 and Reata Pharmaceuticals 200-day simple moving average is 55.00, creating a Buy signal.
RETA Technical Analysis vs Fundamental Analysis
Buy
64
Reata Pharmaceuticals (RETA)
is a Buy
Is Reata Pharmaceuticals a Buy or a Sell?
-
Reata Pharmaceuticals stock is rated a Buy
The current Reata Pharmaceuticals [RETA] share price is $93.80. The Score for RETA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Reata Pharmaceuticals Stock Info
Market Cap:
3.52B
Price in USD:
93.80
Share Volume:
619.16K
Reata Pharmaceuticals 52-Week Range
52-Week High:
106.69
52-Week Low:
18.47
Buy
64
Reata Pharmaceuticals (RETA)
is a Buy
Reata Pharmaceuticals Share Price Forecast
-
What is the Reata Pharmaceuticals stock price today?
The Reata Pharmaceuticals stock price is 93.80 USD today. -
Will RETA stock go up or go down?
Reata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Reata Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reata Pharmaceuticals is not overvalued.
Is Reata Pharmaceuticals Stock a Buy?
- Reata Pharmaceuticals share price is 93.80 while RETA 8-day exponential moving average is 92.69, which is a Buy signal.
- The stock price of RETA is 93.80 while Reata Pharmaceuticals 20-day EMA is 91.62, which makes it a Buy.
- Reata Pharmaceuticals 50-day exponential moving average is 89.11 while RETA share price is 93.80, making it a Buy technically.
- RETA stock price is 93.80 and Reata Pharmaceuticals 200-day simple moving average is 65.78, creating a Buy signal.
Fundamental Analysis of Reata Pharmaceuticals
Is Reata Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $3.96 per share.
Technical Analysis of Reata Pharmaceuticals
Should I short Reata Pharmaceuticals stock?
- RETA Moving Average Covergence Divergence (MACD) indicator is 0.47, suggesting Reata Pharmaceuticals is a Buy
- Reata Pharmaceuticals Relative Strength Index (RSI) is 54.82, which suggest Reata Pharmaceuticals is overbought
- The Bollinger Bands (25) for Reata Pharmaceuticals is (83.19 - 97.77), which suggest Reata Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Reata Pharmaceuticals is (54.93 - 100.63), which suggest Reata Pharmaceuticals is a Buy
* Reata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.